| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/25/2003 | EP0854924B1 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
| 06/25/2003 | EP0840615B1 Chemokine binding protein and methods of use therefor |
| 06/25/2003 | EP0828852B1 Methods for detection and therapy of squamous cell carcinoma and bladder carcinoma, in particular for determining the presence and treatment of minimal residual disease, micrometastases or dissemination of such carcinoma types |
| 06/25/2003 | EP0808172B1 Combination of angiotensin converting enzyme inhibitor and aldosterone antagonist for the treatment of ventricular hypertrophy |
| 06/25/2003 | EP0803256B1 Drug for relieving side effects caused by immunosuppressants |
| 06/25/2003 | EP0744958B1 Polyclonal antibody libraries |
| 06/25/2003 | EP0679182B1 Delivery of gene products via mesangial cells |
| 06/25/2003 | EP0678121B1 Methods and reagents for inhibiting furin endoprotease |
| 06/25/2003 | EP0668879B1 Truncated insulin-like growth factor binding proteins having mitogenic activity |
| 06/25/2003 | EP0618969B1 Composite antibodies of human subgroup iv light chain capable of binding to tag-72 |
| 06/25/2003 | EP0573603B1 Inhibitors of human neutrophil elastase and human cathepsin g |
| 06/25/2003 | CN1426482A Diagnostics and therapeutics for glaucoma |
| 06/25/2003 | CN1426473A Heterologous expression of neisserial proteins |
| 06/25/2003 | CN1426471A Hybrid expression of neisserial proteins |
| 06/25/2003 | CN1426470A Talaromyces emersonii beta-glucanases |
| 06/25/2003 | CN1426468A KCNB: novel potassium channel protein |
| 06/25/2003 | CN1426467A Thrombopoietin receptor modulating peptide |
| 06/25/2003 | CN1426462A Pneumovirus NS proteins antagonising interferon (IFN) response |
| 06/25/2003 | CN1426422A 修饰的bdnf Modified bdnf |
| 06/25/2003 | CN1426421A Tumour-specific animal proteins |
| 06/25/2003 | CN1426420A Novel proteins and novel genes encoding same |
| 06/25/2003 | CN1426308A Utilization of ADAMTS-1 protein and method of screening aggrecanase activity regulator |
| 06/25/2003 | CN1426307A 蛋白质 Protein |
| 06/25/2003 | CN1426306A Method and compositions for impairing multiplication of HIV-1 |
| 06/25/2003 | CN1426304A Chemical Modification of mammalian urine and blood |
| 06/25/2003 | CN1425464A Process for preparing oral insulin nano material |
| 06/25/2003 | CN1425370A Nano grade anti-HIV micro ball |
| 06/25/2003 | CN1112367C Use of pharmaceutical composition comprising appetite-suppressing peptide |
| 06/25/2003 | CN1112215C Use of nerve growth factor in curing organic solvent toxic peripheral neuropathy |
| 06/25/2003 | CN1112184C Melatonin slow-releasing agent and its production process |
| 06/24/2003 | US6583309 Ureas and compositions thereof for treating cancer, inflammation, or a viral infection |
| 06/24/2003 | US6583301 Lipids |
| 06/24/2003 | US6583299 α-amino-β-sulfonyl hydroxamic acid compounds |
| 06/24/2003 | US6583277 Which regulate cellular guidance and physiology, and related nucleic acids. |
| 06/24/2003 | US6583276 Nucleotide sequences coding polypeptide for use in the treatment of cardiovascular disorders |
| 06/24/2003 | US6583272 Protein conjugate for use in the treatment of blood disorders |
| 06/24/2003 | US6583271 Use of thiol redox proteins for reducing protein intramolecular disulfide bonds, for improving the quality of cereal products, dough and baked goods and for inactivating snake, bee and scorpion toxins |
| 06/24/2003 | US6583270 Interleukin-19 |
| 06/24/2003 | US6583268 Especially those present in inclusion bodies in bacterial hosts, by maintaining alkaline pH in presence of chaotrophic or reducing agents, and decreasing pH gradually over given time to induce renaturation; proteomics |
| 06/24/2003 | US6583267 Polyethylene glycol derivative modifying granulocyte colony stimulating factor activity |
| 06/24/2003 | US6583265 Cyclosporins |
| 06/24/2003 | US6583219 Three-dimensional, crosslinked interpenetrating polymer network |
| 06/24/2003 | US6583167 Methods and kits for treating and diagnosing leiomyomas |
| 06/24/2003 | US6583139 Treatment of inflammatory diseases; inflammatory brain diseases such as multiple sclerosis; N-(Toluene-4-sulfonyl)-L-prolyl-4-(alpha -methylbenzyloxy)-L-phenylalanine; Very Late Antigen 4 |
| 06/24/2003 | US6583124 For controlled administration of pharmaceutically active agents to patients, wherein formulation is administered as liquids which thicken to form gels upon instillation into the eye |
| 06/24/2003 | US6583116 Preventing gramnegative bacterial infections by administering synergystic mixtures of bactericidal/permeability-increasing (BPI) proteins and antibiotics |
| 06/24/2003 | US6583115 Methods for treating acromegaly and giantism with growth hormone antagonists |
| 06/24/2003 | US6583114 Fracture healing using pthrp analogs |
| 06/24/2003 | US6583113 Additional smooth muscle relaxant and platelet inhibitory capabilities. |
| 06/24/2003 | US6583111 Use of GLP-1 analogs and derivative adminstered peripherally in regulation of obesity |
| 06/24/2003 | US6583110 Administering antibiotics and amphilic polypeptides for prophylaxis and prevention of sepsis induced by grampositive bacteria |
| 06/24/2003 | US6583108 Human bikunin |
| 06/24/2003 | US6582959 Antibodies to vascular endothelial cell growth factor |
| 06/24/2003 | US6582956 Tumor suppressor gene |
| 06/24/2003 | US6582950 C3 binding polypeptide of Streptococcus agalactiae group b Streptococcus |
| 06/24/2003 | US6582949 Cephaibols: novel antiparasitics from Acremonium tubakii process for their production, and use thereof |
| 06/24/2003 | US6582948 Nucleotide sequences coding polypeptide for use in veterinary medicine |
| 06/24/2003 | US6582947 Nucleotide sequences coding enzymatic polypeptide for use in the virus treatment of cancer and viral infection |
| 06/24/2003 | US6582945 Immunological control of β-amyloid levels in vivo |
| 06/24/2003 | US6582935 Isolated nucleic acid molecules encoding human aspartate aminotransferase protein and uses thereof |
| 06/24/2003 | US6582934 Recombinant DNA encoding an epidermal growth factor receptor related protein |
| 06/24/2003 | US6582933 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of respiratory distress syndrome, asthma, organ rejection, inflammation, arthritis, ischemic, autoimmune, rheumatic and cancer disorders |
| 06/24/2003 | US6582932 Calpain and DNA encoding the same |
| 06/24/2003 | US6582918 Platelet derived growth factor (PDGF) nucleic acid ligand complexes |
| 06/24/2003 | US6582910 WbpP and method for assay of WbpP |
| 06/24/2003 | US6582729 By including water soluble polypeptide; administered by inhalation |
| 06/24/2003 | US6582728 On carrier of human serum albumin, carbohydrate, amino acid, polypeptide, buffer and/or salts; drug delivery to lungs |
| 06/24/2003 | US6582725 Human PEA3 is a tumor suppressor for cancer cells |
| 06/24/2003 | US6582718 Topical, ophthalmic cyclosporin A formulation having better distribution due to surfactant (polyoxyethylene fatty acid esters) causing less irritation to the eyes |
| 06/24/2003 | US6582716 Using insulin pulses to a patient utilizing Chronic Intermittent Intravenous Insulin Therapy to achieve an increase in glucose oxidation in tissues surrounding an affected area |
| 06/24/2003 | US6582713 Compositions and methods for promoting wound healing |
| 06/24/2003 | US6582706 Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural MOTIFS |
| 06/24/2003 | US6582705 Acellular antibordetella vaccine |
| 06/24/2003 | US6582703 Medical diagnosis; amplification primers; genetic engineering |
| 06/24/2003 | US6582701 Equine Fc epsilon receptor alpha chain proteins and uses thereof |
| 06/24/2003 | US6582697 Administering a synthetic conjugate comprising a carbohydrate antigenic determinant and an immunogenic carrier not naturally conjugated with said determinant; tumor prophylaxis and therapy for example |
| 06/24/2003 | US6582695 The use of sphingomyelinase to increase the levels of skin and mucosal ceramides, as well as dermatological and cosmetic compositions containing same which are suitable for topical application are disclosed. |
| 06/24/2003 | US6582690 Process for treating tumors with cytotoxic substances |
| 06/24/2003 | US6582689 Interferon- gamma -inducing factor (IGIF), in combination with a chemotherapeutic agent, processes for making such compositions, the use of such compositions for the prevention and/or treatment of cancer, and the use of such compositions |
| 06/24/2003 | US6582391 Extracorporeal device comprising insoluble collagen fibrils; embedded within matrix are cultured vertebrate cells which secrete polypeptides; shunting patient's blood through apparatus and back into patient; polypeptide mixes with blood |
| 06/24/2003 | CA2223694C Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof |
| 06/24/2003 | CA2171544C Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains |
| 06/24/2003 | CA2165566C Conotoxins having acetylcholin receptor binding properties |
| 06/24/2003 | CA2012311C New protein-polycation-conjugate |
| 06/24/2003 | CA1341433C Purification of interleukin 1 |
| 06/21/2003 | CA2365811A1 A new gene therapy using antisense strategy to estrogen receptors (er .alpha. and/or er .beta.) to optimize vascular healing and cardioprotection after vascular injury |
| 06/19/2003 | WO2003050540A2 Flexible method and apparatus for high throughput production and purification of multiple proteins |
| 06/19/2003 | WO2003050504A2 Methods and compositions to treat cardiovascular disease usin g 1419, 58765 and 2201 |
| 06/19/2003 | WO2003050502A2 Prospective identification and characterization of breast cancer stem cells |
| 06/19/2003 | WO2003050309A1 ANTISENSE MODULATION OF PHOSPHATIDYLINOSITOL-4-PHOSPHATE 5-KINASE, Iα EXPRESSION |
| 06/19/2003 | WO2003050301A2 Susceptibility locus for schizophrenia |
| 06/19/2003 | WO2003050300A2 Diagnosis and treatment of cancer |
| 06/19/2003 | WO2003050293A2 hGC-1, A GENE ENCODING A MEMBER OF THE OLFACTOMEDIN-RELATED PROTEIN FAMILY |
| 06/19/2003 | WO2003050286A1 Methods and means for producing proteins with predetermined post-translational modifications |
| 06/19/2003 | WO2003050285A1 Method for preparing antisense molecules by using bacteriophages with closed single stranded genome and novel antisense molecules produced thereby |
| 06/19/2003 | WO2003050281A2 Fragments of the human zn-alpha2-glycolprotein and their use in methods of treatment of obesity |
| 06/19/2003 | WO2003050280A1 Regulation of human fatty acid binding protein |
| 06/19/2003 | WO2003050258A2 Endogenous retrovirus polypeptides linked to oncogenic transformation |
| 06/19/2003 | WO2003050256A2 Novel human g-protein coupled receptor, hgprbmy34, and variants and methods of use thereof |
| 06/19/2003 | WO2003050255A2 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer |